Renaissance Technologies LLC Buys 114,800 Shares of Cibus, Inc. (NASDAQ:CBUS)

Renaissance Technologies LLC lifted its stake in shares of Cibus, Inc. (NASDAQ:CBUS - Free Report) by 933.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 127,100 shares of the company's stock after purchasing an additional 114,800 shares during the period. Renaissance Technologies LLC owned 0.48% of Cibus worth $353,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in CBUS. Certior Financial Group LLC bought a new stake in Cibus during the fourth quarter worth $236,000. Raymond James Financial Inc. acquired a new position in shares of Cibus during the 4th quarter worth about $89,000. Geode Capital Management LLC raised its holdings in shares of Cibus by 7.5% in the 4th quarter. Geode Capital Management LLC now owns 392,387 shares of the company's stock valued at $1,091,000 after purchasing an additional 27,464 shares during the period. Commonwealth Equity Services LLC acquired a new stake in Cibus in the 4th quarter valued at about $62,000. Finally, Sei Investments Co. bought a new position in Cibus during the fourth quarter worth about $49,000. Institutional investors and hedge funds own 33.81% of the company's stock.

Wall Street Analysts Forecast Growth

CBUS has been the topic of several research analyst reports. HC Wainwright reissued a "buy" rating and issued a $25.00 price objective on shares of Cibus in a research report on Friday, March 21st. Canaccord Genuity Group lowered their price target on shares of Cibus from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Wednesday, January 22nd.

Cibus Stock Performance

CBUS opened at $2.25 on Monday. The stock has a fifty day moving average of $1.95 and a 200-day moving average of $2.87. Cibus, Inc. has a fifty-two week low of $1.40 and a fifty-two week high of $19.56. The company has a market capitalization of $73.91 million, a P/E ratio of -0.10 and a beta of 1.70.

Cibus (NASDAQ:CBUS - Get Free Report) last announced its earnings results on Thursday, March 20th. The company reported ($0.87) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.68) by ($0.19). Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The business had revenue of $1.21 million for the quarter, compared to analyst estimates of $1.13 million. On average, equities research analysts predict that Cibus, Inc. will post -2.96 earnings per share for the current fiscal year.

Cibus Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.